Expand PTGX Menu
PTGX MENU

PTGX Stock Posts


Unusual Option Volume

PTGX Protagonist Therapeutics77.18+1.23 (+1.6%)

Protagonist Therapeutics trades 2,743 contracts. The company has the following event: 67th Annual American Society of Hematology (ASH) Annual Meeting on Dec 6, 2025. News: Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting
View Details...
Unusual Option Volume

PTGX Protagonist Therapeutics80.08-6.92 (-8.0%)

Protagonist Therapeutics trades 3,573 contracts.
View Details...
Unusual Option Volume

PTGX Protagonist Therapeutics89.29+22.25 (+33.2%)

Protagonist Therapeutics trades 2,290 contracts.
View Details...
Unusual Option Volume

PTGX Protagonist Therapeutics57.06-2.70 (-4.5%)

Protagonist Therapeutics trades 3,404 contracts.
View Details...
Unusual Option Volume

PTGX Protagonist Therapeutics57.50+19.15 (+49.9%)

Protagonist Therapeutics trades 2,293 contracts. News: Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis
View Details...
Unusual Option Volume

PTGX Protagonist Therapeutics38.43+0.84 (+2.2%)

Protagonist Therapeutics trades 7,075 contracts. The company has the following event: Protagonist Investor Conference Call and Webcast on Mar 3, 2025. News: Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes